Search the Newsreel

Form 424B5 CRESCENT BIOPHARMA, INC.

Crescent Biopharma, Inc. is offering 8,094,793 ordinary shares and 525,897 pre-funded warrants, with an aim to raise approximately $115.9 million in net proceeds to fund clinical development of its product candidates CR-001, CR-002, and CR-003, as well as for research and development and general …

ACRES Commercial Realty Corp. to Report Results for Second Quarter 2026

ACRES Commercial Realty Corp. (NYSE: ACR) announced it will release its second-quarter 2026 results after market close on Wednesday, July 29, 2026. The company will host a live conference call and webcast on Thursday, July 30, 2026, at 10:00 a.m. Eastern Time for investors …

Crescent Energy (NYSE:CRGY) Stock Rating Upgraded by UBS Group

Crescent Biopharma (Nasdaq: CBIO) prices $125.0 million stock and warrant sale

Crescent Biopharma (Nasdaq: CBIO) has priced a public offering of ordinary shares and pre-funded warrants, aiming to raise approximately $125.0 million in gross proceeds. The offering includes 8,094,793 ordinary shares at $14.50 each and 525,897 pre-funded warrants at $14.499 each. The company expects net …

CRESCENT BIOPHARMA, INC. SEC Filing (Jul 13, 2026)

Crescent Energy Stock Rises 18% in 6 Months: Time to Buy or Stay?

Crescent Energy sets Aug. 4 Q2 call, results after Monday close

FutureCrest Acquisition Corp. (FCRS) Edges Higher in Low-Volume Trading Session - Wave Extension

Crescent Energy (CRGY) Stock Still Looks Cheap As The Market Stays Cautious

Silvercrest Asset Management Group Named to Inaugural CNBC Elite Advisors List of Top Ultra-High-Net-Worth Wealth Management Firms for 2026

Crest Ventures Expands Mumbai Redevelopment Footprint with Landmark Dadar East Cluster Project

Crest Ventures Expands Mumbai Portfolio with Landmark Dadar East Project Worth ₹450 Crore

Crescent Biopharma Shows Strength as Shares Rise Nearly 3% - Cup and Handle

Silvercrest Asset Management Group’s Global Value Opportunity Fund Receives Lonsec ‘Recommended’ Rating in Inaugural Review

CRESY Q1 2026 Earnings: Robust Net Income Amid Challenging Argentine Macro Environment - EBITDA Analysis

Cresud (CRESY) Edges Lower as Consolidation Persists Near Support - Earnings Beat Stocks

Cresud Q1 2026 Earnings: EPS of 614.02 Reported; Shares Slip Amid Limited Disclosure - Estimate Dispersion

Don't Race Out To Buy Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) Just Because It's Going Ex-Dividend

CRESY Q1 2026 Earnings: Argentine Agribusiness Delivers Strong EPS Performance - Estimate Dispersion

Crest Ventures Q4 Profit Rises 9% to ₹8.4 Cr Despite 32% Revenue Drop

Crest Ventures consolidated net profit rises 8.02% in the March 2026 quarter

Silvercrest Asset Management Group Q1 Earnings Call Highlights

Silvercrest (SAMG) Q1 Earnings and Revenues Miss Estimates

Is It Time To Reassess Crescent Energy (CRGY) After Strong 1-Year Share Price Gain?

Rainbows and Unicorns: Crescent Biopharma, Inc. (NASDAQ:CBIO) Analysts Just Became A Lot More Optimistic

Is Crescent Energy Company (CRGY) Outperforming Other Oils-Energy Stocks This Year?

Crescent Energy set to report earnings amid surging oil prices

Crescent Energy (CRGY) Valuation Post Earnings and Expectations

Crest Nicholson shares extend losses as Deutsche Bank and RBC cut targets after profit warning

Broker tips: Crest Nicholson, LBG Media

Crest Nicholson shares fall by a third after profit warning, guidance cut | Financial News

Crest Nicholson issue warning as UK's 5 biggest housebuilders see big share price slumps

Crest Nicholson warns on profit as macro headwinds slow land sales and hit completions

Crest Nicholson Shares Plummet Amidst Bleak Outlook

Crest Nicholson warns over profits amid Iran war impact on costs and demand

Crest Nicholson (LON:CRST) Shares Down 42.6% - Here's Why